Shopping Cart

Bare Metal Stents BMS-Medical Devices Pipeline Assessment, 2016

SKU
GDME0211EPD
READ MORE
USD 2,500
Single User License
USD 2,500
Site License
USD 5,000
Corporate User License
USD 7,500

Bare Metal Stents (BMS)-Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Bare Metal Stents (BMS)-Medical Devices Pipeline Assessment, 2016" provides an overview of Bare Metal Stents (BM

READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Bare Metal Stents (BMS)-Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Bare Metal Stents (BMS)-Medical Devices Pipeline Assessment, 2016" provides an overview of Bare Metal Stents (BMS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bare Metal Stents (BMS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Bare Metal Stents (BMS) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Bare Metal Stents (BMS) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Bare Metal Stents (BMS) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 7

2.1 Bare Metal Stents (BMS) Overview 7

3 Products under Development 8

3.1 Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 8

3.2 Bare Metal Stents (BMS)-Pipeline Products by Territory 9

3.3 Bare Metal Stents (BMS)-Pipeline Products by Regulatory Path 10

3.4 Bare Metal Stents (BMS)-Pipeline Products by Estimated Approval Date 11

3.5 Bare Metal Stents (BMS)-Ongoing Clinical Trials 12

4 Bare Metal Stents (BMS)-Pipeline Products under Development by Companies 13

4.1 Bare Metal Stents (BMS) Companies-Pipeline Products by Stage of Development 13

4.2 Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 14

5 Bare Metal Stents (BMS) Companies and Product Overview 15

5.1 AlviMedica Medical Technologies Inc. Company Overview 15

5.1.1 AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Atrium Medical Corporation Company Overview 19

5.2.1 Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Biotronik SE & Co. KG Company Overview 20

5.3.1 Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 Bolton Medical, Inc. Company Overview 22

5.4.1 Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 Boston Scientific Corporation Company Overview 23

5.5.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 23

5.6 InspireMD, Inc. Company Overview 27

5.6.1 InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 ITGI Medical Ltd. Company Overview 30

5.7.1 ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Medtronic plc Company Overview 31

5.8.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Meril Life Sciences Pvt. Ltd. Company Overview 33

5.9.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 MIV Therapeutics Inc Company Overview 36

5.10.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 Nesstent Ltd. Company Overview 37

5.11.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Nexeon MedSystems, Inc. Company Overview 38

5.12.1 Nexeon MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 Palmaz Scientific, Inc. Company Overview 41

5.13.1 Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41

5.14 Qvanteq AG Company Overview 42

5.14.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 42

5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 45

5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 45

5.16 Stentys SA Company Overview 46

5.16.1 Stentys SA Pipeline Products & Ongoing Clinical Trials Overview 46

5.17 Svelte Medical Systems, Inc. Company Overview 48

5.17.1 Svelte Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

5.18 Vascular Concepts Limited Company Overview 50

5.18.1 Vascular Concepts Limited Pipeline Products & Ongoing Clinical Trials Overview 50

6 Bare Metal Stents (BMS)-Recent Developments 54

6.1 Jun 29, 2016: InspireMD Prices Public Offering of Preferred Stock and Warrants for USD14.6 Million 54

6.2 Jun 17, 2016: ARIAD Completes Strategic Review and Announces Plans for Growth 54

6.3 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 55

6.4 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 55

6.5 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 56

6.6 May 24, 2016: ARIAD Announces Appointment of Jennifer L. Herron as Chief Commercial Officer 58

6.7 May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 59

6.8 May 10, 2016: ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review 60

6.9 May 02, 2016: B. Braun Interventional Systems Extends Exclusive U.S. Distribution Agreement with NuMED 62

6.10 Apr 20, 2016: Abbott Reports First-Quarter 2016 Results 62

6.11 Apr 01, 2016: MicroPort and Yizheng Municipal Government Establishes "Shanghai-Yizheng Healthcare Cooperation Project" 65

6.12 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device 65

6.13 Mar 21, 2016: NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient 65

6.14 Jan 28, 2016: STENTYS: First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs Broadcasted Live at LINC International Congress 66

6.15 Nov 21, 2015: The Registration has been approved in Philippines for WALTZ Cobalt Alloy Stent System 66

6.16 Oct 21, 2015: Abbott Reports Third-Quarter 2015 Results 67

6.17 Aug 03, 2015: Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 68

6.18 Jul 22, 2015: Abbott Reports Second-Quarter 2015 Results 69

7 Appendix 72

7.1 Methodology 72

7.2 About GlobalData 74

7.3 Contact Us 75

7.4 Disclaimer 75


List Of Figure

1.2 List of Figures

Figure 1: Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 8

Figure 2: Bare Metal Stents (BMS)-Pipeline Products by Territory 9

Figure 3: Bare Metal Stents (BMS)-Pipeline Products by Regulatory Path 10

Figure 4: Bare Metal Stents (BMS)-Pipeline Products by Estimated Approval Date 11

Figure 5: Bare Metal Stents (BMS)-Ongoing Clinical Trials 12


List Of Table

1.1 List of Tables

Table 1: Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 8

Table 2: Bare Metal Stents (BMS)-Pipeline Products by Territory 9

Table 3: Bare Metal Stents (BMS)-Pipeline Products by Regulatory Path 10

Table 4: Bare Metal Stents (BMS)-Pipeline Products by Estimated Approval Date 11

Table 5: Bare Metal Stents (BMS)-Ongoing Clinical Trials 12

Table 6: Bare Metal Stents (BMS) Companies-Pipeline Products by Stage of Development 13

Table 7: Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 14

Table 8: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

Table 9: BMS-Avantgarde-Product Status 15

Table 10: BMS-Avantgarde-Product Description 16

Table 11: BMS-Chrono-Product Status 16

Table 12: BMS-Chrono-Product Description 17

Table 13: Tecnic Plus-Product Status 17

Table 14: Tecnic Plus-Product Description 18

Table 15: Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 19

Table 16: Next Generation Super Flexible Cobalt Chromium Coronary Stent-Product Status 19

Table 17: Next Generation Super Flexible Cobalt Chromium Coronary Stent-Product Description 19

Table 18: Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 20

Table 19: AMS-1-Product Status 20

Table 20: AMS-1-Product Description 20

Table 21: AMS-2-Product Status 21

Table 22: AMS-2-Product Description 21

Table 23: Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

Table 24: Spiral Force-Product Status 22

Table 25: Spiral Force-Product Description 22

Table 26: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 23

Table 27: INNOVA Self-Expanding Bare-Metal Stent System-Product Status 23

Table 28: INNOVA Self-Expanding Bare-Metal Stent System-Product Description 24

Table 29: Boston Scientific Corporation-Ongoing Clinical Trials Overview 25

Table 30: INNOVA Self-Expanding Bare-Metal Stent System-Korean Multicenter Registry of INNOVA Stent for Femoropopliteal Artery Disease: (K-INNOVA Registry) 26

Table 31: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

Table 32: MGuard Prime EPS-Product Status 28

Table 33: MGuard Prime EPS-Product Description 29

Table 34: ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30

Table 35: Aneugraft Dx-Product Status 30

Table 36: Aneugraft Dx-Product Description 30

Table 37: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 38: Twin-Rail-Product Status 31

Table 39: Twin-Rail-Product Description 32

Table 40: Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 33

Table 41: Crypton Stainless Steel Coronary Stent System-Product Status 33

Table 42: Crypton Stainless Steel Coronary Stent System-Product Description 34

Table 43: NEXGEN Cobalt Chromium Coronary Stent System-Product Status 34

Table 44: NEXGEN Cobalt Chromium Coronary Stent System-Product Description 35

Table 45: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Table 46: Vestapor-Product Status 36

Table 47: Vestapor-Product Description 36

Table 48: Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 49: NesStent's New Stent-Product Status 37

Table 50: NesStent's New Stent-Product Description 37

Table 51: Nexeon MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 52: PROTEX Coronary Stent System-Product Status 38

Table 53: PROTEX Coronary Stent System-Product Description 39

Table 54: RIVIERA Coronary Stent System-Product Status 39

Table 55: RIVIERA Coronary Stent System-Product Description 40

Table 56: Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41

Table 57: Micro-Grooved Coronary Stent-Product Status 41

Table 58: Micro-Grooved Coronary Stent-Product Description 41

Table 59: Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 42

Table 60: Qstent-Product Status 42

Table 61: Qstent-Product Description 42

Table 62: Qvanteq AG-Ongoing Clinical Trials Overview 43

Table 63: Qstent-Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation 44

Table 64: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 45

Table 65: Bare Metal Coronary Stent-Product Status 45

Table 66: Bare Metal Coronary Stent-Product Description 45

Table 67: Stentys SA Pipeline Products & Ongoing Clinical Trials Overview 46

Table 68: STENTYS Self-Apposing Coronary Stent-Product Status 46

Table 69: STENTYS Self-Apposing Coronary Stent-Product Description 47

Table 70: Svelte Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

Table 71: Svelte Acrobat System-Product Status 48

Table 72: Svelte Acrobat System-Product Description 49

Table 73: Vascular Concepts Limited Pipeline Products & Ongoing Clinical Trials Overview 50

Table 74: ProLink LP-Product Status 50

Table 75: ProLink LP-Product Description 51

Table 76: ProLink SV-Product Status 51

Table 77: ProLink SV-Product Description 51

Table 78: ProPass-Product Status 52

Table 79: ProPass-Product Description 52

Table 80: ProZeta-Product Status 52

Table 81: ProZeta-Product Description 53

Table 82: Glossary 73

To know more information on Purchase by Section, please send a mail to

Products

AlviMedica Medical Technologies Inc., BMS-Avantgarde; AlviMedica Medical Technologies Inc., BMS-Chrono; AlviMedica Medical Technologies Inc., Tecnic Plus; Atrium Medical Corporation, Next Generation Super Flexible Cobalt Chromium Coronary Stent; Biotronik SE &; Co. KG, AMS-1; Biotronik SE &; Co. KG, AMS-2; Bolton Medical, Inc., Spiral Force; Boston Scientific Corporation, INNOVA Self-Expanding Bare-Metal Stent System; InspireMD, Inc., MGuard Prime EPS; ITGI Medical Ltd., Aneugraft Dx; Medtronic plc, Twin-Rail; Meril Life Sciences Pvt. Ltd., Crypton Stainless Steel Coronary Stent System; Meril Life Sciences Pvt. Ltd., NEXGEN Cobalt Chromium Coronary Stent System; MIV Therapeutics Inc, Vestapor; Nesstent Ltd., NesStent's New Stent; Nexeon MedSystems, Inc., PROTEX Coronary Stent System; Nexeon MedSystems, Inc., RIVIERA Coronary Stent System; Palmaz Scientific, Inc., Micro-Grooved Coronary Stent; Qvanteq AG, Qstent; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Bare Metal Coronary Stent; Stentys SA, STENTYS Self-Apposing Coronary Stent; Svelte Medical Systems, Inc., Svelte Acrobat System; Vascular Concepts Limited, ProLink LP; Vascular Concepts Limited, ProLink SV; Vascular Concepts Limited, ProPass; Vascular Concepts Limited, ProZeta

Companies

AlviMedica Medical Technologies Inc.

Atrium Medical Corporation

Biotronik SE & Co. KG

Bolton Medical, Inc.

Boston Scientific Corporation

InspireMD, Inc.

ITGI Medical Ltd.

Medtronic plc

Meril Life Sciences Pvt. Ltd.

MIV Therapeutics Inc

Nesstent Ltd.

Nexeon MedSystems, Inc.

Palmaz Scientific, Inc.

Qvanteq AG

Sree Chitra Tirunal Institute for Medical Sciences & Technology

Stentys SA

Svelte Medical Systems, Inc.

Vascular Concepts Limited

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.